메뉴 건너뛰기




Volumn 28, Issue 2, 2007, Pages 103-111

Improving the outcome of established therapies for osteoporosis by adding the active D-hormone analog alfacalcidol

Author keywords

Alendronate; Alfacalcidol; Combined treatments; Osteoporosis; Vitamin D

Indexed keywords

ALENDRONIC ACID; ALFACALCIDOL; BISPHOSPHONIC ACID DERIVATIVE; CALCITONIN; CALCITRIOL; CALCIUM; COLECALCIFEROL; D HORMONE; FLUORIDE; HORMONE; OXYGENASE; PARATHYROID HORMONE[1-34]; RALOXIFENE; STRONTIUM RANELATE; UNCLASSIFIED DRUG; VITAMIN D;

EID: 36148938348     PISSN: 01728172     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00296-007-0422-6     Document Type: Review
Times cited : (21)

References (62)
  • 1
    • 36148969155 scopus 로고    scopus 로고
    • Perspectives of combined treatment strategies in osteoporosis
    • Suppl 2
    • Ringe JD (2000) Perspectives of combined treatment strategies in osteoporosis. J Menopause 7(Suppl 2):22-23
    • (2000) J Menopause , vol.7 , pp. 22-23
    • Ringe, J.D.1
  • 2
    • 0033305354 scopus 로고    scopus 로고
    • Monofluorophosphate combined with hormone replacement therapy induces a synergistic effect on bone mass by dissociating bone formation and resorption in postmenopausal women: A randomized study
    • Alexandersen P, Riis BJ, Christiansen C (1999) Monofluorophosphate combined with hormone replacement therapy induces a synergistic effect on bone mass by dissociating bone formation and resorption in postmenopausal women: a randomized study. J Clin Endocriol Metab 84:3013-3020
    • (1999) J Clin Endocriol Metab , vol.84 , pp. 3013-3020
    • Alexandersen, P.1    Riis, B.J.2    Christiansen, C.3
  • 4
    • 0035985563 scopus 로고    scopus 로고
    • Monofluorophosphate combined with hormone replacement therapy in postmenopausal osteoporosis. An open-label pilot efficacy and safety study
    • Ringe JD, Setnikar I (2002) Monofluorophosphate combined with hormone replacement therapy in postmenopausal osteoporosis. An open-label pilot efficacy and safety study. Rheumatol Int 22:27-32
    • (2002) Rheumatol Int , vol.22 , pp. 27-32
    • Ringe, J.D.1    Setnikar, I.2
  • 6
    • 0034762411 scopus 로고    scopus 로고
    • Treatment of osteoporosis in men with fluoride alone or in combination with bisphosphonates
    • Ringe JD, Rovati L (2001) Treatment of osteoporosis in men with fluoride alone or in combination with bisphosphonates. Calcif Tissue Int 69:252-255
    • (2001) Calcif Tissue Int , vol.69 , pp. 252-255
    • Ringe, J.D.1    Rovati, L.2
  • 8
    • 20044389711 scopus 로고    scopus 로고
    • Efficacy of etidronate and sequential monofluorophosphate in severe postmenopausal osteoporosis: A pilot study
    • Ringe JD, Dorst A, Faber H, Kipshoven C, Rovati LC, Setnikar I (2005) Efficacy of etidronate and sequential monofluorophosphate in severe postmenopausal osteoporosis: a pilot study. Rheumatol Int 25:296-300
    • (2005) Rheumatol Int , vol.25 , pp. 296-300
    • Ringe, J.D.1    Dorst, A.2    Faber, H.3    Kipshoven, C.4    Rovati, L.C.5    Setnikar, I.6
  • 10
    • 0029091836 scopus 로고
    • The anabolic effect of human PTH (1-34) on bone formation is blunted when bone resorption is inhibited by the bisphosphonate tiludronat. Is activated resorption a prerequisite for the in vivo effect of PTH on formation in a remodeling system?
    • Delmas PD, Vergnaud P, Arlot ME, Pastoureau P, Meunier PJ, Nilssen MH (1995) The anabolic effect of human PTH (1-34) on bone formation is blunted when bone resorption is inhibited by the bisphosphonate tiludronat. Is activated resorption a prerequisite for the in vivo effect of PTH on formation in a remodeling system? Bone 16:603-610
    • (1995) Bone , vol.16 , pp. 603-610
    • Delmas, P.D.1    Vergnaud, P.2    Arlot, M.E.3    Pastoureau, P.4    Meunier, P.J.5    Nilssen, M.H.6
  • 12
    • 0031969747 scopus 로고    scopus 로고
    • Effects of combined treatment with calcitriol plus alendronate on bone mass and bone turnover in postmenopausal osteoporosis. Two years of continuous treatment
    • Frediani B, Allegri A, Bisohno S, Marcolongo R (1998) Effects of combined treatment with calcitriol plus alendronate on bone mass and bone turnover in postmenopausal osteoporosis. Two years of continuous treatment. Clin Drug Invest 14:235-244
    • (1998) Clin Drug Invest , vol.14 , pp. 235-244
    • Frediani, B.1    Allegri, A.2    Bisohno, S.3    Marcolongo, R.4
  • 14
    • 0026653787 scopus 로고
    • Differences in vitamin D status between countries in young adults and the elderly
    • McKenna MJ (1992) Differences in vitamin D status between countries in young adults and the elderly. Am J Med 93:69-77
    • (1992) Am J Med , vol.93 , pp. 69-77
    • McKenna, M.J.1
  • 15
    • 0029915542 scopus 로고    scopus 로고
    • Healthy elderly French women living at home have secondary hyperparathyroidism and high bone turnover in winter
    • Chapuy MC, Schott AM, Garnero P, Hans D, Delmas P, Meunier PJ (1996) Healthy elderly French women living at home have secondary hyperparathyroidism and high bone turnover in winter. J Clin Endocrinol Metab 81:1129-1133
    • (1996) J Clin Endocrinol Metab , vol.81 , pp. 1129-1133
    • Chapuy, M.C.1    Schott, A.M.2    Garnero, P.3    Hans, D.4    Delmas, P.5    Meunier, P.J.6
  • 19
    • 0030763532 scopus 로고    scopus 로고
    • Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age and older
    • Dawson-Hughes B, Harris SS, Krall EA, Dallal GE (1997) Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age and older. N Engl J Med 337:670-676
    • (1997) N Engl J Med , vol.337 , pp. 670-676
    • Dawson-Hughes, B.1    Harris, S.S.2    Krall, E.A.3    Dallal, G.E.4
  • 21
    • 0036679437 scopus 로고    scopus 로고
    • Meta-analysis of the efficacy of vitamin D treatment in preventing osteoporosis in postmenopausal women
    • Papadimitropoulos E, Wells G, Shea B (2002) Meta-analysis of the efficacy of vitamin D treatment in preventing osteoporosis in postmenopausal women. Endocr Rev 23:560-569
    • (2002) Endocr Rev , vol.23 , pp. 560-569
    • Papadimitropoulos, E.1    Wells, G.2    Shea, B.3
  • 22
    • 18744369929 scopus 로고    scopus 로고
    • 3 and calcium for secondary prevention of low-trauma fractures in elderly people (Randomised Evaluation of Calcium or vitamin D, RECORD): A randomised placebo-controlled trial
    • The RECORD Trial group
    • 3 and calcium for secondary prevention of low-trauma fractures in elderly people (Randomised Evaluation of Calcium OR vitamin D, RECORD): a randomised placebo-controlled trial. Lancet 365:1621-1628
    • (2005) Lancet , vol.365 , pp. 1621-1628
  • 23
    • 18744416279 scopus 로고    scopus 로고
    • Vitamin D and fractures: Quo vadis ?
    • Sambrook P (2005) Vitamin D and fractures: quo vadis ? Lancet 365:1599-1600
    • (2005) Lancet , vol.365 , pp. 1599-1600
    • Sambrook, P.1
  • 26
    • 0032887590 scopus 로고    scopus 로고
    • Vitamin D therapy of osteoporosis: Plain vitamin D therapy versus active vitamin D analog (D-hormone) therapy
    • Lau KHW, Baylink DJ (1999) Vitamin D therapy of osteoporosis: plain vitamin D therapy versus active vitamin D analog (D-hormone) therapy. Calcif Tissue Int 65:295-306
    • (1999) Calcif Tissue Int , vol.65 , pp. 295-306
    • Lau, K.H.W.1    Baylink, D.J.2
  • 27
    • 4043178630 scopus 로고    scopus 로고
    • Prevention and therapy of osteoporosis: The roles of plain vitamin D and alfacalcidol
    • Ringe JD, Schacht E (2004) Prevention and therapy of osteoporosis: the roles of plain vitamin D and alfacalcidol. Rheumatol Int 24:189-197
    • (2004) Rheumatol Int , vol.24 , pp. 189-197
    • Ringe, J.D.1    Schacht, E.2
  • 30
    • 15044353492 scopus 로고    scopus 로고
    • Effect of annual intramuscular vitamin D supplementation on fracture risk: Population-based, randomised, double-blind, placebo-controlled trial
    • Smith H, Anderson F, Raphael H, Crozier S, Cooper C (2004) Effect of annual intramuscular vitamin D supplementation on fracture risk: population-based, randomised, double-blind, placebo-controlled trial. Osteoporos Int 15:S8
    • (2004) Osteoporos Int , vol.15 , pp. 8
    • Smith, H.1    Anderson, F.2    Raphael, H.3    Crozier, S.4    Cooper, C.5
  • 31
    • 0031697518 scopus 로고    scopus 로고
    • Vitamin D deficiency and osteopathies
    • Suppl 1
    • Ringe JD (1998) Vitamin D deficiency and osteopathies. Osteoporos Int 8(Suppl 1):S35-S39
    • (1998) Osteoporos Int , vol.8
    • Ringe, J.D.1
  • 34
    • 0025284734 scopus 로고
    • Hypoparathyroidism: Practice and theoretical background for 1α-OH-D treatment
    • Ogata E (1990) Hypoparathyroidism: practice and theoretical background for 1α-OH-D treatment. Bone Miner 9:229-232
    • (1990) Bone Miner , vol.9 , pp. 229-232
    • Ogata, E.1
  • 36
    • 24944489965 scopus 로고    scopus 로고
    • Alfacalcidol versus plain vitamin D in inflammation induced bone loss
    • Scharla SH, Schacht E, Lempert UG (2005) Alfacalcidol versus plain vitamin D in inflammation induced bone loss. J Rheumatol 32:26-32
    • (2005) J Rheumatol , vol.32 , pp. 26-32
    • Scharla, S.H.1    Schacht, E.2    Lempert, U.G.3
  • 38
    • 3042600925 scopus 로고    scopus 로고
    • The effects of calcitriol on falls and fractures and physical performance test's
    • Gallagher JC (2004) The effects of calcitriol on falls and fractures and physical performance test's. J Steroid Biochem Mol Biol 89-90:497-501
    • (2004) J Steroid Biochem Mol Biol , vol.89-90 , pp. 497-501
    • Gallagher, J.C.1
  • 41
    • 24944452519 scopus 로고    scopus 로고
    • Multifactorial pathogenesis of falls as a basis for multifactorial interventions
    • Runge M, Schacht E (2005) Multifactorial pathogenesis of falls as a basis for multifactorial interventions. J Musculoskelet Neuronal Interact 5:127-134
    • (2005) J Musculoskelet Neuronal Interact , vol.5 , pp. 127-134
    • Runge, M.1    Schacht, E.2
  • 42
    • 34547866998 scopus 로고    scopus 로고
    • Effects of combined treatment with alendronate and alfacalcidol on bone mineral density and bone turnover in postmenopausal osteoporosis: A two-years, randomized, multiarm, controlled trial
    • Ones K, Schacht E, Dukas L, Caglar N (2007) Effects of combined treatment with alendronate and alfacalcidol on bone mineral density and bone turnover in postmenopausal osteoporosis: a two-years, randomized, multiarm, controlled trial. Int J Epidemiol 4(1)
    • (2007) Int J Epidemiol , vol.4 , Issue.1
    • Ones, K.1    Schacht, E.2    Dukas, L.3    Caglar, N.4
  • 43
  • 44
    • 36148994167 scopus 로고    scopus 로고
    • Effects of alfacalcidol and alendronate on bone in previously untreated postmenopausal women with osteopenia or osteoporosis: One year interim subgroup analysis of the alfa study
    • Bock O, Boerst H, Runge M, Armbrecht G, Martus P, Schacht E, Hashimoto J, Felsenberg D (2007) Effects of alfacalcidol and alendronate on bone in previously untreated postmenopausal women with osteopenia or osteoporosis: one year interim subgroup analysis of the alfa study. Bone 40:S253
    • (2007) Bone , vol.40 , pp. 253
    • Bock, O.1    Boerst, H.2    Runge, M.3    Armbrecht, G.4    Martus, P.5    Schacht, E.6    Hashimoto, J.7    Felsenberg, D.8
  • 45
    • 0031821010 scopus 로고    scopus 로고
    • Effects of cyclical etidronate combined with calcitriol versus cyclical etidronate alone on spine and femoral neck bone mineral density in postmenopausal osteoporotic women
    • Masud T, Mulcahy B, Thompson AV, Donnelly S, Keen RW, Doyle DV, Spector TD (1998) Effects of cyclical etidronate combined with calcitriol versus cyclical etidronate alone on spine and femoral neck bone mineral density in postmenopausal osteoporotic women. Ann Rheum Dis 57:346-349
    • (1998) Ann Rheum Dis , vol.57 , pp. 346-349
    • Masud, T.1    Mulcahy, B.2    Thompson, A.V.3    Donnelly, S.4    Keen, R.W.5    Doyle, D.V.6    Spector, T.D.7
  • 46
    • 0041511959 scopus 로고    scopus 로고
    • Effects of cyclical etidronate with alfacalcidol on lumbar bone mineral density, bone resorption, and back pain in postmenopausal women with osteoporosis
    • Iwamoto J, Takeda T, Ichimura S, Matsu K, Uzawa M (2003) Effects of cyclical etidronate with alfacalcidol on lumbar bone mineral density, bone resorption, and back pain in postmenopausal women with osteoporosis. J Orthop Sci 8:532-537
    • (2003) J Orthop Sci , vol.8 , pp. 532-537
    • Iwamoto, J.1    Takeda, T.2    Ichimura, S.3    Matsu, K.4    Uzawa, M.5
  • 47
    • 0035059058 scopus 로고    scopus 로고
    • Effect of intermittent cyclical treatment with etidronate disodium (HEBP) and calcium plus alfacalcidol in postmenopausal osteoporosis
    • Shiota E, Tsuchiya K, Yamaoka K, Kawano O (2001) Effect of intermittent cyclical treatment with etidronate disodium (HEBP) and calcium plus alfacalcidol in postmenopausal osteoporosis. J Orthop Sci 6:133-136
    • (2001) J Orthop Sci , vol.6 , pp. 133-136
    • Shiota, E.1    Tsuchiya, K.2    Yamaoka, K.3    Kawano, O.4
  • 49
    • 0041805424 scopus 로고    scopus 로고
    • Bone mineral and collagen quality in numeri of ovariectomized cynomolgus monkeys given rhPTH(1-34) for 18 months
    • Paschalis EP, Burr DB, Mendelsohn R, Hock JM, Boskey AL (2003) Bone mineral and collagen quality in numeri of ovariectomized cynomolgus monkeys given rhPTH(1-34) for 18 months. J Bone Miner Res 18:769-775
    • (2003) J Bone Miner Res , vol.18 , pp. 769-775
    • Paschalis, E.P.1    Burr, D.B.2    Mendelsohn, R.3    Hock, J.M.4    Boskey, A.L.5
  • 50
    • 0012171602 scopus 로고
    • 3 and low dose intermittent elcalcitonin (eel calcitonin derivative)
    • 3 and low dose intermittent elcalcitonin (eel calcitonin derivative). JBBM 10:37-40
    • (1992) JBBM , vol.10 , pp. 37-40
    • Fujita, T.1    Fukase, M.2    Shimada, T.3    Yamamoto, H.4
  • 51
    • 0035861468 scopus 로고    scopus 로고
    • Effects of combined use of calcitonin and 1α-hydroxycholecalciferol on vertebral bone loss and bone turnover in women with postmenopausal osteopenia and osteoporosis: A prospective study of long-term and continuous administration with low dose calcitonin
    • Ushiroyama T, Ikeda A, Sakai M, Higashiyama T, Ueki M (2001) Effects of combined use of calcitonin and 1α-hydroxycholecalciferol on vertebral bone loss and bone turnover in women with postmenopausal osteopenia and osteoporosis: a prospective study of long-term and continuous administration with low dose calcitonin. Maturitas 40:229-238
    • (2001) Maturitas , vol.40 , pp. 229-238
    • Ushiroyama, T.1    Ikeda, A.2    Sakai, M.3    Higashiyama, T.4    Ueki, M.5
  • 52
    • 0034891341 scopus 로고    scopus 로고
    • Combination treatment with estrogen and calcitriol in prevention of age-related bone loss
    • Gallagher JC, Fowler SE, Detter JR, Sherman SS (2001) Combination treatment with estrogen and calcitriol in prevention of age-related bone loss. J Clin Endocrinol Metab 86:3618-3628
    • (2001) J Clin Endocrinol Metab , vol.86 , pp. 3618-3628
    • Gallagher, J.C.1    Fowler, S.E.2    Detter, J.R.3    Sherman, S.S.4
  • 54
    • 36148982872 scopus 로고    scopus 로고
    • Raloxifene when combined with 1α(OH)vitamin D more greatly suppresses bone turnover and increases bone density than when used alone in postmenopausal Japanese women with osteoporosis or osteopenia
    • Suppl 1
    • Gorai I, Tanaka Y, Iwacki Y (2006) Raloxifene when combined with 1α(OH)vitamin D more greatly suppresses bone turnover and increases bone density than when used alone in postmenopausal Japanese women with osteoporosis or osteopenia. J Bone Miner Res 21(Suppl 1):S186
    • (2006) J Bone Miner Res , vol.21 , pp. 186
    • Gorai, I.1    Tanaka, Y.2    Iwacki, Y.3
  • 55
    • 33847138963 scopus 로고    scopus 로고
    • Superiority of a combined treatment of alendronate and alfacalcidol compared to the combination of alendronate and plain vitamin D or alfacalcidol alone in established postmenopausal or male osteoporosis (AAC-trial)
    • Ringe JD, Farahmand P, Schacht E, Rozenal A (2007) Superiority of a combined treatment of alendronate and alfacalcidol compared to the combination of alendronate and plain vitamin D or alfacalcidol alone in established postmenopausal or male osteoporosis (AAC-trial). Rheumatol Int 27:425-428
    • (2007) Rheumatol Int , vol.27 , pp. 425-428
    • Ringe, J.D.1    Farahmand, P.2    Schacht, E.3    Rozenal, A.4
  • 56
    • 34247627002 scopus 로고    scopus 로고
    • Secondary hyperparathyroidism due to hypovitaminosis D affects bone mineral response to alendronate in elderly women with osteoporosis: A randomized controlled trial
    • Barone A, Giusti A, Piolu G, Girasole G, Razzano M, Palummeri E, Bianchi G (2007) Secondary hyperparathyroidism due to hypovitaminosis D affects bone mineral response to alendronate in elderly women with osteoporosis: a randomized controlled trial. J Am Geriatr Soc 55:752-757
    • (2007) J Am Geriatr Soc , vol.55 , pp. 752-757
    • Barone, A.1    Giusti, A.2    Piolu, G.3    Girasole, G.4    Razzano, M.5    Palummeri, E.6    Bianchi, G.7
  • 57
    • 0033504941 scopus 로고    scopus 로고
    • The role of vitamin D in corticosteroid-induced osteoporosis: A meta-analytic approach
    • Amin S, LaValley MP, Simms RW, Felson DT (1999) The role of vitamin D in corticosteroid-induced osteoporosis: a meta-analytic approach. Arthritis Rheum 42:1740-1751
    • (1999) Arthritis Rheum , vol.42 , pp. 1740-1751
    • Amin, S.1    Lavalley, M.P.2    Simms, R.W.3    Felson, D.T.4
  • 58
    • 2142820079 scopus 로고    scopus 로고
    • Efficacy of alphacalcidol and calcitriol in primary and corticosteroid-induced osteoporosis: A meta-analysis of their effects on bone mineral density and fracture rate
    • Richy F, Ethgen O, Bruyere O, Reginster J-Y (2004) Efficacy of alphacalcidol and calcitriol in primary and corticosteroid-induced osteoporosis: a meta-analysis of their effects on bone mineral density and fracture rate. Osteoporos Int 15:301-310
    • (2004) Osteoporos Int , vol.15 , pp. 301-310
    • Richy, F.1    Ethgen, O.2    Bruyere, O.3    Reginster, J.-Y.4
  • 59
    • 21344472972 scopus 로고    scopus 로고
    • Vitamin D analogs versus native vitamin D in preventing bone loss and osteoporosis-related fractures. a comparative meta-analysis
    • Richy F, Schacht E, Bruyère O, Ethgen O, Gourlay M, Reginster JY (2005) Vitamin D analogs versus native vitamin D in preventing bone loss and osteoporosis-related fractures. A comparative meta-analysis. Calcif Tissue Int 76:176-186
    • (2005) Calcif Tissue Int , vol.76 , pp. 176-186
    • Richy, F.1    Schacht, E.2    Bruyère, O.3    Ethgen, O.4    Gourlay, M.5    Reginster, J.Y.6
  • 60
    • 1642320904 scopus 로고    scopus 로고
    • Superiority of alfacalcidol over plain vitamin D in the treatment of glucocorticoid-induced osteoporosis
    • Ringe JD, Dorst A, Faber H, Schacht E, Rahlfs VW (2004) Superiority of alfacalcidol over plain vitamin D in the treatment of glucocorticoid-induced osteoporosis. Rheumatol Int 24:63-70
    • (2004) Rheumatol Int , vol.24 , pp. 63-70
    • Ringe, J.D.1    Dorst, A.2    Faber, H.3    Schacht, E.4    Rahlfs, V.W.5
  • 62
    • 0034071834 scopus 로고    scopus 로고
    • Prevention of corticosteroid-induced osteoporosis by alphacalcidol
    • Suppl 1
    • Lakatos P, Nagy Z, Kiss L, Horvath C, Takacs I, Foldes J, et al (2000) Prevention of corticosteroid-induced osteoporosis by alphacalcidol. Z Rheumatol 59(Suppl 1):48-61
    • (2000) Z Rheumatol , vol.59 , pp. 48-61
    • Lakatos, P.1    Nagy, Z.2    Kiss, L.3    Horvath, C.4    Takacs, I.5    Foldes, J.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.